ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-02-26
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-03-31 was 2.11%, a 52.90% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-03-31 was 1.38%.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2013-03-31 was 0.99%.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.17%, a 35.83% increase from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 3.07%, a 223.16% increase from fiscal 2021.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.95%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-02-26 | |
| 2023-12-31 | 4.17% 10-K · filed 2025-02-26 | |
| 2022-12-31 | 3.07% 10-K · filed 2024-03-12 | |
| 2021-12-31 | 0.95% 10-K · filed 2023-03-01 | |
| 2017-03-31 | 2.11% 10-Q · filed 2017-05-09 | |
| 2016-03-31 | 1.38% 10-Q · filed 2016-05-06 | |
| 2013-03-31 | 0.99% 10-Q/A · filed 2013-08-19 | |
| 2010-12-31 | 2.36% 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |